{"id":908219,"date":"2025-11-10T21:17:07","date_gmt":"2025-11-11T02:17:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/"},"modified":"2025-11-10T21:17:07","modified_gmt":"2025-11-11T02:17:07","slug":"hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/","title":{"rendered":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Nov. 10, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <b>Class Action Attorney <\/b><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=3725037534&amp;u=https%3A%2F%2Fprofiles.superlawyers.com%2Fnew-york%2Fnew-york%2Flawyer%2Fjuan-e-monteverde%2Fb861d99b-d20f-4376-92c4-2996390bacbc.html&amp;a=Juan+Monteverde\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-person\">Juan Monteverde<\/span><\/a><b>\u00a0with <\/b><u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=2760151197&amp;u=http%3A%2F%2Fwww.monteverdelaw.com%2F&amp;a=Monteverde+%26+Associates+PC\" target=\"_blank\" rel=\"nofollow\">Monteverde &amp; Associates PC<\/a><\/u>\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a <b>Top 50\u00a0Firm <\/b>in the 2024 ISS Securities Class Action Services Report. We are headquartered at the<b>\u00a0Empire State Building<\/b>\u00a0in <span class=\"xn-location\">New York City<\/span> and are investigating<\/p>\n<ul type=\"disc\">\n<li>\n          <b>Cartica Acquisition Corp. (OTCMKTS: <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=2691761715&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FCRTAF%2F&amp;a=CRTAF\" target=\"_blank\" rel=\"nofollow\">CRTAF<\/a>) <\/b>related to its merger with Nidar Infrastructure Ltd., in which the pre-transaction equity value of Nidar implied by the proposed transaction&#8217;s terms is approximately\u00a0$2.75 billion.<\/li>\n<\/ul>\n<p>\n        <b>ACT NOW. The Shareholder Vote is scheduled for <span class=\"xn-chron\">November 28, 2025<\/span>.<\/b>\n      <\/p>\n<p>\n        <b>Click here for more information <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=1634454236&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcartica-acquisition-corp%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fcartica-acquisition-corp%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/monteverdelaw.com\/case\/cartica-acquisition-corp\/<\/a><\/b><br \/>\n        <b>.<\/b><br \/>\n        <b>\u00a0It is free and there is no cost or obligation to you.<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Akero Therapeutics, Inc. (NASDAQ:<\/b><br \/>\n          <b>\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=2969280448&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FAKRO%2F&amp;a=AKRO\" target=\"_blank\" rel=\"nofollow\">AKRO<\/a>) <\/b>related to its sale to Novo Nordisk A\/S. Under the terms of the proposed transaction, Akero shareholders will receive <span class=\"xn-money\">$54.00<\/span> per share in cash, and a non-transferable contingent value right entitling its holder to receive a cash payment of <span class=\"xn-money\">$6.00<\/span> per share upon full U.S. regulatory approval of efruxifermin by <span class=\"xn-chron\">June 30, 2031<\/span>.<\/li>\n<\/ul>\n<p>\n        <b>ACT NOW. The Shareholder Vote is scheduled for <span class=\"xn-chron\">December 2, 2025<\/span>. <\/b>\n      <\/p>\n<p>\n        <b>Click here for more information<\/b><br \/>\n        <b><br \/>\n          <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=1873544949&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fakero-therapeutics-inc%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fakero-therapeutics-inc%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/monteverdelaw.com\/case\/akero-therapeutics-inc\/<\/a><br \/>\n        <\/b><br \/>\n        <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=264976568&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpremier-inc%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fpremier-inc%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/monteverdelaw.com\/case\/premier-inc\/<\/a><br \/>\n        <b>.<\/b><br \/>\n        <b>\u00a0It is free and there is no cost or obligation to you.<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Adverum Biotechnologies, Inc. (NASDAQ: <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=1567584177&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FNIC%2F&amp;a=NIC\" target=\"_blank\" rel=\"nofollow\">NIC<\/a>) <\/b>related to its sale to Eli Lilly and Company. Under the terms of the proposed transaction, Adverum shareholders will receive <span class=\"xn-money\">$3.56<\/span> per share in cash plus one non-transferable contingent value right (&#8220;CVR&#8221;) entitling the holder to receive up to an additional <span class=\"xn-money\">$8.91<\/span> per CVR in cash upon the achievement of two certain milestones.<\/li>\n<\/ul>\n<p>\n        <b>ACT NOW. The Tender Offer expires on <span class=\"xn-chron\">December 8, 2025<\/span>.<\/b>\n      <\/p>\n<p>\n        <b>Click here for more information <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=3874822605&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fadverum-biotechnologies-inc%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fadverum-biotechnologies-inc%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/monteverdelaw.com\/case\/adverum-biotechnologies-inc\/<\/a><\/b><br \/>\n        <b>.<\/b><br \/>\n        <b>\u00a0It is free and there is no cost or obligation to you.<\/b>\n      <\/p>\n<ul type=\"disc\">\n<li>\n          <b>Barinthus Biotherapeutics plc (NASDAQ: <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=3097766412&amp;u=https%3A%2F%2Ffinance.yahoo.com%2Fquote%2FBRNS%2F&amp;a=BRNS\" target=\"_blank\" rel=\"nofollow\">BRNS<\/a>) <\/b>related to its merger with Clywedog Therapeutics, Inc. Under the terms of the proposed transaction, Barinthus shareholders will receive one share of common stock in the new combined company for each American Depository Share or ordinary share owned, and Clywedog shareholders will receive 4.358932 shares of common stock in the new combined company for each common or preferred share owned.<\/li>\n<\/ul>\n<p>\n        <b>Click here for more info<\/b><br \/>\n        <b><br \/>\n          <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=3869002232&amp;u=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fbarinthus-biotherapeutics-plc%2F&amp;a=https%3A%2F%2Fmonteverdelaw.com%2Fcase%2Fbarinthus-biotherapeutics-plc%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/monteverdelaw.com\/case\/barinthus-biotherapeutics-plc\/<\/a><br \/>\n        <\/b><br \/>\n        <b>.<\/b><br \/>\n        <b>It is free and there is no cost or obligation to you.<\/b>\n      <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1406\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg\" title=\"Monteverde &amp; Associates PC Logo\" alt=\"Monteverde &amp; Associates PC Logo\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\n        <b>NOT ALL LAW FIRMS ARE THE SAME. <\/b>Before you hire a law firm, you should talk to a lawyer and ask:<\/p>\n<ol type=\"1\">\n<li>Do you file class actions and go to Court?<\/li>\n<li>When was the last time you recovered money for shareholders?<\/li>\n<li>What cases did you recover money in and how much?<\/li>\n<\/ol>\n<p>\n        <b>About Monteverde &amp; Associates PC<\/b>\n      <\/p>\n<p>Our firm litigates and has recovered money for shareholders\u2026and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S.\u00a0Supreme Court.\u00a0<\/p>\n<p>\n        <b>No company, director or officer is above the law.<\/b>\u00a0If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our <b><u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=3339217484&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D2503619756%26u%3Dhttps%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwebsite&amp;a=website\" target=\"_blank\" rel=\"nofollow\">website<\/a><\/u><\/b> or contact <span class=\"xn-person\">Juan Monteverde, Esq.<\/span> either via e-mail at <b><u><a href=\"mailto:jmonteverde@monteverdelaw.com\" target=\"_blank\" rel=\"nofollow\">jmonteverde@monteverdelaw.com<\/a><\/u><\/b> or by telephone at (212) 971-1341.<\/p>\n<p>Contact:<br \/><span class=\"xn-person\">Juan Monteverde, Esq.<\/span><br \/>MONTEVERDE &amp; ASSOCIATES PC<br \/><b>The Empire State Building<br \/><\/b>350 Fifth Ave. Suite 4740<br \/><span class=\"xn-location\">New York, NY<\/span> 10118<br \/><span class=\"xn-location\">United States of America<\/span><br \/><u><a href=\"mailto:jmonteverde@monteverdelaw.com\" target=\"_blank\" rel=\"nofollow\">jmonteverde@monteverdelaw.com<\/a><\/u><br \/>Tel: (212) 971-1341<\/p>\n<p>Attorney Advertising. (C) 2025 Monteverde &amp; Associates PC.\u00a0The law firm responsible for this advertisement is Monteverde &amp; Associates PC (<u><a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4554351-1&amp;h=2929469793&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D2721435-1%26h%3D4276761662%26u%3Dhttp%253A%252F%252Fwww.monteverdelaw.com%252F%26a%3Dwww.monteverdelaw.com&amp;a=www.monteverdelaw.com\" target=\"_blank\" rel=\"nofollow\">www.monteverdelaw.com<\/a><\/u>). Prior results do not guarantee a similar outcome with respect to any future matter.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=DC20387&amp;sd=2025-11-10\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-mergercrtaf-akro-nic-and-brns-302610615.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-mergercrtaf-akro-nic-and-brns-302610615.html<\/a><\/p>\n<p>SOURCE  Monteverde &amp; Associates PC<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DC20387&amp;Transmission_Id=202511101730PR_NEWS_USPR_____DC20387&amp;DateId=20251110\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , Nov. 10, 2025 \/PRNewswire\/ &#8212; Class Action Attorney Juan Monteverde\u00a0with Monteverde &amp; Associates PC\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the\u00a0Empire State Building\u00a0in New York City and are investigating Cartica Acquisition Corp. (OTCMKTS: CRTAF) related to its merger with Nidar Infrastructure Ltd., in which the pre-transaction equity value of Nidar implied by the proposed transaction&#8217;s terms is approximately\u00a0$2.75 billion. ACT NOW. The Shareholder Vote is scheduled for November 28, 2025. Click here for more information https:\/\/monteverdelaw.com\/case\/cartica-acquisition-corp\/ . \u00a0It is free and there is no cost or obligation to you. Akero &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-908219","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Nov. 10, 2025 \/PRNewswire\/ &#8212; Class Action Attorney Juan Monteverde\u00a0with Monteverde &amp; Associates PC\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the\u00a0Empire State Building\u00a0in New York City and are investigating Cartica Acquisition Corp. (OTCMKTS: CRTAF) related to its merger with Nidar Infrastructure Ltd., in which the pre-transaction equity value of Nidar implied by the proposed transaction&#8217;s terms is approximately\u00a0$2.75 billion. ACT NOW. The Shareholder Vote is scheduled for November 28, 2025. Click here for more information https:\/\/monteverdelaw.com\/case\/cartica-acquisition-corp\/ . \u00a0It is free and there is no cost or obligation to you. Akero &hellip; Continue reading &quot;$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T02:17:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS\",\"datePublished\":\"2025-11-11T02:17:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/\"},\"wordCount\":637,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/\",\"name\":\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\",\"datePublished\":\"2025-11-11T02:17:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/443626\\\/Monteverde_Associates_PC_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/","og_locale":"en_US","og_type":"article","og_title":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS - Market Newsdesk","og_description":"PR Newswire NEW YORK , Nov. 10, 2025 \/PRNewswire\/ &#8212; Class Action Attorney Juan Monteverde\u00a0with Monteverde &amp; Associates PC\u00a0(the &#8220;M&amp;A Class Action Firm&#8221;), has recovered millions of dollars for shareholders and is recognized as a Top 50\u00a0Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the\u00a0Empire State Building\u00a0in New York City and are investigating Cartica Acquisition Corp. (OTCMKTS: CRTAF) related to its merger with Nidar Infrastructure Ltd., in which the pre-transaction equity value of Nidar implied by the proposed transaction&#8217;s terms is approximately\u00a0$2.75 billion. ACT NOW. The Shareholder Vote is scheduled for November 28, 2025. Click here for more information https:\/\/monteverdelaw.com\/case\/cartica-acquisition-corp\/ . \u00a0It is free and there is no cost or obligation to you. Akero &hellip; Continue reading \"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-11T02:17:07+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS","datePublished":"2025-11-11T02:17:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/"},"wordCount":637,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/","name":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","datePublished":"2025-11-11T02:17:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/443626\/Monteverde_Associates_PC_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hareholder-alert-the-ma-class-action-firm-continues-to-investigate-the-merger-crtaf-akro-nic-and-brns\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"$HAREHOLDER ALERT: The M&amp;A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=908219"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908219\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=908219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=908219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=908219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}